Results 61 to 70 of about 40,902 (256)
Cytokine Pathways Driving Diverse Tissue Pathologies in Rheumatoid Arthritis
Arthritis &Rheumatology, EarlyView.Rheumatoid arthritis (RA) is a complex systemic disorder characterized primarily by articular inflammation and destruction with associated functional loss and reduced quality of life. RA is also associated with extra‐articular disease, such as that of the lung, with potentially devastating clinical consequences. The critical importance of comorbidities,
Aurelie Najm +2 more
wiley +1 more source
DiaDENS-Cardio potential in resistant arterial hypertension treatment
Кардиоваскулярная терапия и профилактика, 2009 Aim. To investigate a new technique of transcutaneous electroneurostimulation of reflexogenic zones by shortimpulse current (DiaDENS-Cardio) as a potential method to improve blood pressure (BP) control in patients with arterial hypertension (AH ...
G. A. Svintsova +4 more
doaj
The Relationship between Resistant Hypertension and Arterial Stiffness
Clinical and Experimental Hypertension, 2011 With growing awareness of arterial stiffness (AS) in the past 10 years, it was realized that resistant hypertension (RH) and AS share the same associated conditions such as older age, isolated systolic hypertension (HT), obesity, chronic kidney disease (CKD), and so on. Until now, there is no study investigating the role of AS in RH.
AKDENİZ, BAHRİ +4 more
openaire +3 more sources
Arthritis &Rheumatology, EarlyView.Objective Immune complexes (ICs), formed by autoantigen and autoantibody, play a pathogenic role in systemic autoimmune diseases through stimulation of Fcγ receptors (FcγR). However, studies investigating bioactivity of circulating ICs across various diseases remain limited.
Koji Suzuki +8 more
wiley +1 more source
Resistant Hypertension and Obstructive Sleep Apnea: The Sparring Partners
International Journal of Hypertension, 2011 Enhanced target organ damage and cardiovascular morbidity represent common issues observed in both resistant hypertension and obstructive sleep apnea.
Costas Thomopoulos +4 more
doaj +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić +4 more
wiley +1 more source
Non drowsy obstructive sleep apnea as a potential cause of resistant hypertension: a case report
BMC Pulmonary Medicine, 2012 Background Obstructive sleep apnea (OSA) and arterial hypertension (AH) are common and underrecognized medical disorders. OSA is a potential risk factor for the development of AH and/or may act as a factor complicating AH management.
Mirrakhimov Aibek E
doaj +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims To determine the prevalence of non‐adherence to antihypertensive medicines and to identify demographic and behavioral factors associated with non‐adherence in subjects enrolled in the May Measurement Month (MMM) 2023, as part of the permanent public health action Hunting the silent killer.
Valerija Bralić Lang +12 more
wiley +1 more source
Паёми Сино, 2017 Objective: To study the influence of gender stereotypes of personality (GSP) and family settings (FS) on the course of arterial hypertension (AH) in middle-aged patients.
G.M. NEGMATOVA +3 more
doaj +1 more source
British Journal of Clinical Pharmacology, EarlyView.SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić +7 more
wiley +1 more source